Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,400 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 5 February 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download: 

(PDF, 3MB, 197 pages)

 

Export 178 results:
Author [ Title(Desc)] Type Year
Filters: Author is Jick, S. S.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
N. Frey, Bodmer, M., Bircher, A., Jick, S. S., Meier, C. R., and Spoendlin, J., “Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study”, Drug Saf, vol. 42, pp. 55-66, 2019.
S. S. Jick, Vasilakis, C., Martinez, C., and Jick, H., “A study of the relation of exposure to quinolones and suicidal behaviour”, Br J Clin Pharmacol, vol. 45, pp. 77-81, 1998.
J. Spoendlin, Voegel, J. J., Jick, S. S., and Meier, C. R., “A study on the epidemiology of rosacea in the U.K”, Br J Dermatol, vol. 167, pp. 598-605, 2012.
N. A. Stohler, Reinau, D., Jick, S. S., Bodmer, D., and Meier, C. R., “A study on the epidemiology of tinnitus in the United Kingdom”, Clin Epidemiol, vol. 11, pp. 855-871, 2019.
T
B. D. Bradbury, Lash, T. L., Kaye, J. A., and Jick, S. S., “Tamoxifen and cataracts: a null association”, Breast Cancer Res Treat, vol. 87, pp. 189-96, 2004.
B. D. Bradbury, Lash, T. L., Kaye, J. A., and Jick, S. S., “Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina”, Cancer, vol. 103, pp. 1114-21, 2005.
A. M. Pfeil, Imfeld, P., Pettengell, R., Jick, S. S., Szucs, T. D., Meier, C. R., and Schwenkglenks, M., “Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD)”, Ann Hematol, vol. 94, pp. 421-9, 2015.
N. Frey, Hugle, T., Jick, S. S., Meier, C. R., and Spoendlin, J., “Type II diabetes mellitus and incident osteoarthritis of the hand: a population-based case-control analysis”, Osteoarthritis Cartilage, vol. 24, pp. 1535-40, 2016.
U
J. D. Orlander, Jick, S. S., Dean, A. D., and Jick, H., “Urinary tract infections and estrogen use in older women”, J Am Geriatr Soc, vol. 40, pp. 817-20, 1992.
E. Hak, Mulder, B., Schuiling-Veninga, C. C., de Vries, T. W., and Jick, S. S., “Use of acid-suppressive drugs in pregnancy and the risk of childhood asthma: bidirectional crossover study using the general practice research database”, Drug Saf, vol. 36, pp. 1097-104, 2013.
M. Bodmer, Becker, C., Meier, C., Jick, S. S., and Meier, C. R., “Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis”, Am J Gastroenterol, vol. 107, pp. 620-6, 2012.
C. Schneider, Adamcova, M., Jick, S. S., Schlagenhauf, P., Miller, M. K., Rhein, H. G., and Meier, C. R., “Use of anti-malarial drugs and the risk of developing eye disorders”, Travel Med Infect Dis, vol. 12, pp. 40-7, 2014.
R. G. Schlienger, Kraenzlin, M. E., Jick, S. S., and Meier, C. R., “Use of beta-blockers and risk of fractures”, Jama, vol. 292, pp. 1326-32, 2004.
C. Seliger, Meier, C. R., Jick, S. S., Uhl, M., Bogdahn, U., Hau, P., and Leitzmann, M. F., “Use of cardiac glycosides and risk of glioma”, J Neurooncol, vol. 127, pp. 321-8, 2016.
C. Meier, Brauchli, Y. B., Jick, S. S., Kraenzlin, M. E., and Meier, C. R., “Use of depot medroxyprogesterone acetate and fracture risk”, J Clin Endocrinol Metab, vol. 95, pp. 4909-16, 2010.
S. Bruderer, Bodmer, M., Jick, S. S., and Meier, C. R., “Use of diuretics and risk of incident gout: a population-based case-control study”, Arthritis Rheumatol, vol. 66, pp. 185-96, 2014.
M. Bodmer, Becker, C., Meier, C., Jick, S. S., and Meier, C. R., “Use of metformin and the risk of ovarian cancer: a case-control analysis”, Gynecol Oncol, vol. 123, pp. 200-4, 2011.
M. Bodmer, Becker, C., Meier, C., Jick, S. S., and Meier, C. R., “Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis”, Cancer Epidemiol Biomarkers Prev, vol. 21, pp. 280-6, 2012.
C. Seliger, Meier, C. R., Becker, C., Jick, S. S., Bogdahn, U., Hau, P., and Leitzmann, M. F., “Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma”, PLoS One, vol. 11, p. e0149293, 2016.
C. Becker, Jick, S. S., and Meier, C. R., “Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK”, Drug Saf, vol. 31, pp. 399-407, 2008.
C. Meier, Kraenzlin, M. E., Bodmer, M., Jick, S. S., Jick, H., and Meier, C. R., “Use of thiazolidinediones and fracture risk”, Arch Intern Med, vol. 168, pp. 820-5, 2008.
T. Burkard, Moser, M., Rauch, M., Jick, S. S., and Meier, C. R., “Utilization pattern of hormone therapy in UK general practice between 1996 and 2015: a descriptive study”, Menopause, 2019.
V
K. W. Hagberg and Jick, S. S., “Validation of autism spectrum disorder diagnoses recorded in the Clinical Practice Research Datalink, 1990-2014”, Clin Epidemiol, vol. 9, pp. 475-482, 2017.
H. Jick, Jick, S. S., and Derby, L. E., “Validation of information recorded on general practitioner based computerised data resource in the United Kingdom”, Bmj, vol. 302, pp. 766-8, 1991.
N. Frey, Bircher, A., Bodmer, M., Jick, S. S., Meier, C. R., and Spoendlin, J., “Validation of Stevens-Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research Datalink”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 429-436, 2017.
S. S. Jick, Kaye, J. A., Vasilakis-Scaramozza, C., Rodriguez, L. A. Garcia, Ruigomez, A., Meier, C. R., Schlienger, R. G., Black, C., and Jick, H., “Validity of the general practice research database”, Pharmacotherapy, vol. 23, pp. 686-9, 2003.
W
A. M. Mueller, Meier, C. R., Jick, S. S., and Schneider, C., “Weight change and blood glucose concentration as markers for pancreatic cancer in subjects with new-onset diabetes mellitus: A matched case-control study”, Pancreatology, 2019.
C. C. Yang, Jick, S. S., and Testa, M. A., “Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiation”, Br J Clin Pharmacol, vol. 55, pp. 288-98, 2003.
[Page last reviewed 5 February 2020]